DFX Intelligence

Data Factory

Blue Owl Capital Holdings LP

Office on the family office graph

This is the graph view. The full profile, with its team, deals and sources, is on Family Offices.Open the full profile →

Search this name across graphsid dfx:fo:7581e24e-a2e6-4522-8383-c46f22067c15

Data as of an unrecorded date (this record's last observation) from Sworn filings; Announcements. Page built Sep 21, 2026, 3:40 AM UTC and rebuilt at most every 15 minutes.

Relationships: 99
Dated events: 40
On other graphs: 0
Observed: n/a to n/a

Across DFX

This entity has not been resolved onto another DFX graph by a shared identifier. A name match elsewhere would be a candidate, never an identity, and none is recorded.

People

Person	Title	Role	Seniority	Family member	Current	Evidence
Karen Hager	Chief Compliance Officer	operations	unknown	n/a	yes	fact

Relationships

showing 80 of 99

Related to (80)

→ Wndrco Holdings II LPFunda foundation at the office's address (PETER G PETERSON FOUNDATION) holds it
inferenceForm 990-PF
→ Welsh, Carson, Anderson & Stowe Xi, LPFunda foundation at the office's address (PETER G PETERSON FOUNDATION) holds it
inferenceForm 990-PF
→ Whale Rock Flagship Fund LtdFunda foundation at the office's address (PETER G PETERSON FOUNDATION) holds it
inferenceForm 990-PF
→ White Deer Energy LP IIFunda foundation at the office's address (PETER G PETERSON FOUNDATION) holds it
inferenceForm 990-PF
→ Abrams Capital Partners IIFunda foundation at the office's address (PETER G PETERSON FOUNDATION) holds it
inferenceForm 990-PF
→ ACE Redpoint Opportunity China, L.P.Funda foundation at the office's address (PETER G PETERSON FOUNDATION) holds it
inferenceForm 990-PF
→ ACE Redpoint Ventures China II, L.P.Funda foundation at the office's address (PETER G PETERSON FOUNDATION) holds it
inferenceForm 990-PF
→ ACE Redpoint Ventures China III, L.P.Funda foundation at the office's address (PETER G PETERSON FOUNDATION) holds it
inferenceForm 990-PF
→ Activum Sg Feeder Fund V LPFunda foundation at the office's address (PETER G PETERSON FOUNDATION) holds it
inferenceForm 990-PF
→ Altas Partners Holdings (a) LPFunda foundation at the office's address (PETER G PETERSON FOUNDATION) holds it
inferenceForm 990-PF
→ Altas Partners Holdings II LPFunda foundation at the office's address (PETER G PETERSON FOUNDATION) holds it
inferenceForm 990-PF
→ Altas Partners Holdings III LPFunda foundation at the office's address (PETER G PETERSON FOUNDATION) holds it
inferenceForm 990-PF
→ Amansa Feeder, Ltd.Funda foundation at the office's address (PETER G PETERSON FOUNDATION) holds it
inferenceForm 990-PF
→ American Securities Partners VIFunda foundation at the office's address (PETER G PETERSON FOUNDATION) holds it
inferenceForm 990-PF
→ APH St. Augustine Holdings (a) LPFunda foundation at the office's address (PETER G PETERSON FOUNDATION) holds it
inferenceForm 990-PF
→ Arrowstreet Capital Global Equity Alpha Extension Fund LimitedFunda foundation at the office's address (PETER G PETERSON FOUNDATION) holds it
inferenceForm 990-PF
→ Artemis Real Estate Partners Fund II, LPFunda foundation at the office's address (PETER G PETERSON FOUNDATION) holds it
inferenceForm 990-PF
→ Axon Partners (offshore), Ltd (f/k/a Tpg)Funda foundation at the office's address (PETER G PETERSON FOUNDATION) holds it
inferenceForm 990-PF
→ Baupost Value Partners LP IVFunda foundation at the office's address (PETER G PETERSON FOUNDATION) holds it
inferenceForm 990-PF
→ Cantillon Global EquityFunda foundation at the office's address (PETER G PETERSON FOUNDATION) holds it
inferenceForm 990-PF
→ Centerbridge Credit Partners Te, L.P.Funda foundation at the office's address (PETER G PETERSON FOUNDATION) holds it
inferenceForm 990-PF
→ Cyrus Opportunities Fund II, LtdFunda foundation at the office's address (PETER G PETERSON FOUNDATION) holds it
inferenceForm 990-PF
→ Cyrus Select Opportunities Fund, LtdFunda foundation at the office's address (PETER G PETERSON FOUNDATION) holds it
inferenceForm 990-PF
→ Cyrus Select Opportunities Master Fund II, LtdFunda foundation at the office's address (PETER G PETERSON FOUNDATION) holds it
inferenceForm 990-PF
→ Denham Commodity Partners Fund Vi-A LPFunda foundation at the office's address (PETER G PETERSON FOUNDATION) holds it
inferenceForm 990-PF
→ Dragoneer Global Offshore Feeder II, L.P.Funda foundation at the office's address (PETER G PETERSON FOUNDATION) holds it
inferenceForm 990-PF
→ Echo Street Goodco Select II, LPFunda foundation at the office's address (PETER G PETERSON FOUNDATION) holds it
inferenceForm 990-PF
→ Encap Energy Capital Fund IxFunda foundation at the office's address (PETER G PETERSON FOUNDATION) holds it
inferenceForm 990-PF
→ Encap Energy Capital Fund Viii-B LPFunda foundation at the office's address (PETER G PETERSON FOUNDATION) holds it
inferenceForm 990-PF
→ Encap Energy Capital Fund XFunda foundation at the office's address (PETER G PETERSON FOUNDATION) holds it
inferenceForm 990-PF
and 50 more

Dated events

40 bookkeeping events (roster, classification and holdings changes) folded below

Show 40 bookkeeping events

First seen by DFX
Sep 12, 2026
date not stated
Blue Owl Capital Holdings LP: CANDIDATE_FAMILY_OFFICE -> NOT_FAMILY_OFFICE (files S-4 with the SEC: a public company or its treasury, not an office)
First seen by DFX
Sep 12, 2026
date not stated
Blue Owl Capital Holdings LP files Form 13F (non_adviser_filer, $324,037,144 in 83 positions)
Occurred
May 14, 2026
Blue Owl Capital Holdings LP reported $372,172,997 across 76 13(f) positions for the quarter ended 2026-03-31
Occurred
Mar 31, 2026
Blue Owl Capital Holdings LP exited Immuneering Corp (was $4,375,700, 665,000 shares)
Occurred
Mar 31, 2026
Blue Owl Capital Holdings LP exited Roivant Sciences Ltd (was $5,712,503, 263,249 shares)
Occurred
Mar 31, 2026
Blue Owl Capital Holdings LP exited Mineralys Therapeutics Inc (was $2,393,108, 65,944 shares)
Occurred
Mar 31, 2026
Blue Owl Capital Holdings LP exited Procore Technologies Inc (was $6,856,765, 94,264 shares)
Occurred
Mar 31, 2026
Blue Owl Capital Holdings LP exited Centessa Pharmaceuticals Plc (was $3,487,645, 139,450 shares)
Occurred
Mar 31, 2026
Blue Owl Capital Holdings LP exited Repare Therapeutics Inc (was $8,953,513, 3,443,659 shares)
Occurred
Mar 31, 2026
Blue Owl Capital Holdings LP exited NU Hldgs Ltd (was $2,910,634, 173,873 shares)
Occurred
Mar 31, 2026
Blue Owl Capital Holdings LP increased Aquestive Therapeutics Inc 525,000 -> 1,347,932 shares ($3,391,500 -> $5,593,918)
Occurred
Mar 31, 2026
Blue Owl Capital Holdings LP opened a $2,730,145 position in Starwood Ppty Tr Inc (158,545 shares)
Occurred
Mar 31, 2026
Blue Owl Capital Holdings LP reduced Dell Technologies Inc 53,848 -> 13,899 shares ($6,778,386 -> $2,281,243)
Occurred
Mar 31, 2026
Blue Owl Capital Holdings LP opened a $5,344,741 position in Rhythm Pharmaceuticals Inc (61,455 shares)
Occurred
Mar 31, 2026
Blue Owl Capital Holdings LP exited Payoneer Global Inc (was $3,978,333, 832,810 shares)
Occurred
Mar 31, 2026
Blue Owl Capital Holdings LP reduced Sagimet Biosciences Inc 1,243,877 -> 333,877 shares ($7,363,752 -> $1,744,507)
Occurred
Mar 31, 2026
Blue Owl Capital Holdings LP opened a $7,973,350 position in Corvus Pharmaceuticals Inc (545,000 shares)
Occurred
Mar 31, 2026
Blue Owl Capital Holdings LP reduced Eledon Pharmaceuticals Inc 1,929,912 -> 1,419,912 shares ($2,914,167 -> $4,373,329)
Occurred
Mar 31, 2026
Blue Owl Capital Holdings LP opened a $2,299,000 position in Evommune Inc (100,000 shares)
Occurred
Mar 31, 2026
Blue Owl Capital Holdings LP opened a $4,228,359 position in Ovid Therapeutics Inc (1,904,666 shares)
Occurred
Mar 31, 2026
Blue Owl Capital Holdings LP increased Ultragenyx Pharmaceutical in 212,638 -> 302,638 shares ($4,890,674 -> $6,340,266)
Occurred
Mar 31, 2026
Blue Owl Capital Holdings LP reduced Civeo Corp Cda 370,530 -> 180,475 shares ($8,474,021 -> $4,775,369)
Occurred
Mar 31, 2026
Blue Owl Capital Holdings LP reduced Oric Pharmaceuticals Inc 515,000 -> 150,000 shares ($4,212,700 -> $1,900,500)
Occurred
Mar 31, 2026
Blue Owl Capital Holdings LP increased Engene Holdings Inc 3,360,937 -> 4,416,353 shares ($30,349,261 -> $30,075,364)
Occurred
Mar 31, 2026
Blue Owl Capital Holdings LP increased Eyepoint Inc 392,594 -> 912,594 shares ($7,172,692 -> $11,763,337)
Occurred
Mar 31, 2026
Blue Owl Capital Holdings LP increased Lenz Therapeutics Inc 150,000 -> 506,722 shares ($2,400,000 -> $4,636,506)
Occurred
Mar 31, 2026
Blue Owl Capital Holdings LP increased Maplight Therapeutics Inc 327,058 -> 1,005,929 shares ($5,744,774 -> $20,450,537)
Occurred
Mar 31, 2026
Blue Owl Capital Holdings LP reduced Context Therapeutics Inc 7,432,906 -> 5,089,015 shares ($10,926,372 -> $13,333,219)
Occurred
Mar 31, 2026
Blue Owl Capital Holdings LP reduced Immix Biopharma Inc 986,240 -> 547,552 shares ($5,158,035 -> $4,988,199)
Occurred
Mar 31, 2026
Blue Owl Capital Holdings LP reduced Kalvista Pharmaceuticals Inc 360,000 -> 215,000 shares ($5,814,000 -> $4,327,950)
Occurred
Mar 31, 2026
Blue Owl Capital Holdings LP exited Compass Pathways Plc (was $3,242,407, 469,914 shares)
Occurred
Mar 31, 2026
Blue Owl Capital Holdings LP opened a $56,556,516 position in Aktis Oncology Inc (3,161,348 shares)
Occurred
Mar 31, 2026
Blue Owl Capital Holdings LP opened a $5,133,907 position in Compass Pathways Plc (1,804,504 shares)
Occurred
Feb 20, 2026
Blue Owl Capital Holdings LP reported $324,037,144 across 83 13(f) positions for the quarter ended 2025-12-31
Occurred
Dec 31, 2025
Blue Owl Capital Holdings LP opened a $5,744,774 position in Maplight Therapeutics Inc (327,058 shares)
Occurred
Dec 31, 2025
Blue Owl Capital Holdings LP opened a $2,400,000 position in Lenz Therapeutics Inc (150,000 shares)
Occurred
Dec 31, 2025
Blue Owl Capital Holdings LP opened a $5,158,035 position in Immix Biopharma Inc (986,240 shares)
Occurred
Dec 31, 2025
Blue Owl Capital Holdings LP increased Compass Therapeutics Inc 2,591,525 -> 3,466,525 shares ($9,070,338 -> $18,615,239)
Occurred
Dec 31, 2025
Blue Owl Capital Holdings LP reduced Aquestive Therapeutics Inc 1,250,000 -> 525,000 shares ($6,987,500 -> $3,391,500)
Occurred
Dec 31, 2025
Blue Owl Capital Holdings LP opened a $6,856,765 position in Procore Technologies Inc (94,264 shares)

Who to call

the organisation, the role and the published line, with the filing or website that published it; revealed to signed-in accounts

The firm's published line

Revealable: 1 office address (Form 13F) · as of 2026-05-14

Karen Hager
Chief Compliance Officer · Revealable: 2 business phones (Form 13F)

Who to call is the organisation, the person's role and the line they published themselves: a business phone, office address, website or profile link from Form ADV, Form 13F or their own website, with that source named on every value. The counts above are what a reveal returns; a personal email is rarely published, so most reveals are the firm's line. Never data bought from a provider, never anything personal. Reveals by plan

Provenance

Graph: Family Offices
Canonical id: dfx:fo:7581e24e-a2e6-4522-8383-c46f22067c15
First observed: n/a
Last observed: n/a : not yet measured
Resolution: Identity across graphs by shared identifier (CRD, CIK, EIN, ADV fund id, individual CRD) or citation; a name match is shown as a candidate and never merged.

Blue Owl Capital Holdings LP

Office on the family office graph

This is the graph view. The full profile, with its team, deals and sources, is on Family Offices.Open the full profile →

Search this name across graphsid dfx:fo:7581e24e-a2e6-4522-8383-c46f22067c15

Data as of an unrecorded date (this record's last observation) from Sworn filings; Announcements. Page built Sep 21, 2026, 3:40 AM UTC and rebuilt at most every 15 minutes.

Person

Title

Role

Seniority

Family member

Current

Evidence

Karen Hager

Chief Compliance Officer

operations

unknown

n/a

yes

fact